The Scottish eHealth Informatics Research Centre (E-HIRCs) (Joint with Universities of Aberdeen, Glasgow, Edinburgh, Strathclyde, St Andrews & Leicester and ISD)

Medicine & Life Sciences

1. Child Health 100%
2. Genome-Wide Association Study 79%
3. Datasets 72%
4. Myalgia 55%
5. Exome 47%
6. Mental Health 42%
7. Hydroxymethylglutaryl-CoA Reductase Inhibitors 41%
8. Type 2 Diabetes Mellitus 41%
9. Population 41%
10. Scotland 40%
11. Child 38%
12. Randomized Controlled Trials 37%
13. Gene Frequency 36%
14. Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 36%
15. Big Data 34%
16. Multimorbidity 33%
17. Attention Deficit Disorder with Hyperactivity 31%
18. Semantic Web 31%
19. Genes 31%
20. Infant Health 30%
21. Creatine Kinase 29%
22. Eczema 28%
23. Parenting 28%
24. Population Health 27%
25. Neoplasm Antigens 26%
26. Genetic Association Studies 26%
27. Cohort Studies 26%
28. Vasculitis 25%
29. Energy Intake 25%
30. Radiology 25%
31. Ambulatory Care 24%
32. Alleles 24%
33. Autoantibodies 23%
34. Antihypertensive Agents 23%
35. Information Storage and Retrieval 22%
36. Energy Metabolism 22%
37. Coronary Artery Disease 20%
38. Fasting 20%
39. Lung Neoplasms 19%
40. Body Mass Index 19%
41. Observational Studies 19%
42. Insulin 19%
43. Software 18%
44. Systematic Reviews 18%
45. Health 18%
46. Heart Rate 18%
47. Obesity 17%
48. Blood Pressure 17%
49. Anti-Bacterial Agents 16%
50. Odds Ratio 15%
51. Lung 14%
52. Kidney 13%
53. Insulin-Like Growth Factor Binding Protein 4 12%
54. Morbidity 12%
55. Pregnancy-Associated Plasma Protein-A 12%
56. Genome 11%
57. Health Expenditures 11%
58. Proteins 11%
59. Pharmaceutical Preparations 10%
60. Growth Disorders 10%
61. Multifactorial Inheritance 10%
62. Sample Size 10%
63. Unemployment 10%
64. Proteoglycans 9%
65. Labetalol 9%
66. Methyldopa 8%
67. Glycosaminoglycans 8%
68. Somatomedins 8%
69. Databases 8%
70. Pleckstrin Homology Domains 8%
71. Meta-Analysis 8%
72. Fetal Mortality 8%
73. Library Science 8%
74. Cardiovascular Diseases 8%
75. Hypertension 8%
76. Phenotype 8%
77. Muscles 8%
78. Emollients 8%
79. Hospitalization 7%
80. Adipocytes 7%
81. Pregnancy 7%
82. Biological Availability 7%
83. Health Education 7%
84. Cost-Benefit Analysis 7%
85. Rosuvastatin Calcium 7%
86. Costs and Cost Analysis 7%
87. Clonidine 7%
88. Delivery of Health Care 6%
89. Deep Learning 6%
90. Sleep Wake Disorders 6%
91. Therapeutics 6%
92. Low Birth Weight Infant 6%
93. Artificial Intelligence 6%
94. Premature Birth 6%
95. X Ray Computed Tomography 6%
96. Vulnerable Populations 6%
97. Incidence 6%
98. Research Personnel 6%
99. Mutation 6%
100. Checklist 6%
101. Genetic Variation 6%
102. Privacy 6%
103. Terminator Codon 6%
104. Confidence Intervals 5%
105. Placebos 5%
106. Machine Learning 5%
107. Patient Care 5%
108. Mobile Applications 5%
109. Population Control 5%
110. Gestational Age 5%
111. Clinical Decision-Making 5%
112. Early Detection of Cancer 5%
113. Publications 5%
114. Insulin Resistance 5%
115. Phlebotomy 5%